ATRX and cancer: RAD54 deletion imparts sensitivity to DNA damaging agents (18, 19), causes defects in strand invasion (20, 21), leads to the accumulation of toxic HR intermediates (22), and rad54 missense mutations have been linked to human cancers (23, 24).